Mitosis as an anti-cancer drug target
Author:
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Genetics
Link
http://link.springer.com/content/pdf/10.1007/s00412-013-0419-8.pdf
Reference267 articles.
1. Abrieu A, Magnaghi-Jaulin L, Kahana JA, Peter M, Castro A, Vigneron S, Lorca T, Cleveland DW, Labbe JC (2001) Mps1 is a kinetochore-associated kinase essential for the vertebrate mitotic checkpoint. Cell 106:83–93
2. Ahn CH, Kim YR, Kim SS, Yoo NJ, Lee SH (2009) Mutational analysis of TTK gene in gastric and colorectal cancers with microsatellite instability. Cancer Res Treat 41:224–228. doi: 10.4143/crt.2009.41.4.224
3. Aihara A, Tanaka S, Yasen M et al (2010) The selective Aurora B kinase inhibitor AZD1152 as a novel treatment for hepatocellular carcinoma. J Hepatol 52:63–71. doi: 10.1016/j.jhep.2009.10.013
4. Al-Janadi A, Chandana SR, Conley BA (2008) Histone deacetylation: an attractive target for cancer therapy? Drugs R D 9:369–383
5. Allan LA, Clarke PR (2007) Phosphorylation of caspase-9 by CDK1/cyclin B1 protects mitotic cells against apoptosis. Mol Cell 26:301–310. doi: 10.1016/j.molcel.2007.03.019
Cited by 46 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The therapeutic effect of KSP inhibitors in preclinical models of cholangiocarcinoma;Cell Death & Disease;2022-09-19
2. Pan-cancer analysis of pathway-based gene expression pattern at the individual level reveals biomarkers of clinical prognosis;Cell Reports Methods;2021-08
3. Eg5 as a Prognostic Biomarker and Potential Therapeutic Target for Hepatocellular Carcinoma;Cells;2021-07-05
4. Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumors;Cell Death & Disease;2021-03
5. Mechanism of intrinsic resistance of lung squamous cell carcinoma to epithelial growth factor receptor‑tyrosine kinase inhibitors revealed by high‑throughput RNA interference screening;Oncology Letters;2020-10-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3